Pernix Commences Refinancing Transactions to Fortify Balance Sheet
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- US stocks close down as oil spikes 12%, job market weakens
- U.S. nonfarm payroll employment unexpectedly falls in February
- Oracle stock falls on report of scrapped Texas data center plans
- Kuwait cuts oil output as storage fills up
- Boeing reportedly nearing 500-aircraft deal with China ahead of Trump visit
- After-hours movers: Marvell, Samsara, GAP, Cooper Cos.
- After-hours movers: Broadcom, StubHub, Cracker Barrel, Grocery Outlet, Veeva Systems and more
- After-hours movers: Moderna, CrowdStrike, Ross Stores, Box and more
- After-hours movers: MongoDB, Credo, SoFi Technologies and more
- After-hours movers: Dell, Block, CoreWeave, Autodesk, MARA and more
Pernix Therapeutics (PTX) Reports Prelim. Q2 Revenue of $33M-$35M
July 20, 2017 4:57 PM UTCPernix Therapeutics Holdings, Inc. (NASDAQ: PTX) today announced certain preliminary unaudited financial results for the second quarter ended June 30, 2017.
Second Quarter 2017 Preliminary Unaudited Financial Highlights:
Second quarter 2017 net revenues are expected to be between $33.0 million and $35.0 million, which would represent a decrease of between 5% and 10% versus second quarter 2016 net revenues of $36.7 million.Second quarter 2017 selling, general and administrative expense is expected to be between $18.0... More